{"id":946523,"date":"2026-03-24T10:27:03","date_gmt":"2026-03-24T14:27:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/"},"modified":"2026-03-24T10:27:03","modified_gmt":"2026-03-24T14:27:03","slug":"lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/","title":{"rendered":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, March  24, 2026  (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>REGENXBIO Inc. (RGNX)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against REGENXBIO Inc. (\u201cREGENXBIO\u201d) (NASDAQ: RGNX) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding the efficacy and safety of REGENXBIO\u2019s RGX-111 trial study between <strong>February 9, 2022 and January 27<\/strong>, <strong>2026<\/strong>. If you purchased REGENXBIO shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N95eFUWfGz5xdCjlqBlHdnefBzPgzAuujIkmWWLfR9FcFMRHX3jmmXy9ZElOwoMNnF4CEIp2EjEk9XKzSyMMXClUU2TTATsoQcbxPhbHrvU=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n1-SFfejekyIjZgH4o9xZIWL7fVC6Tauan0tRSSGdt_y8HHljJIy5Nw4OtlKbmpGJuDOYrQlpkNUK7YE2eRu_oD5TzJp06Ct4sPBNILTM82z3aHp7N7VjIGeiP0U5ie8C84B3-850Sgev1xTuFEmLg==\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/regenxbio\/<\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is\u00a0April 14, 2026. <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Franklin BSP Realty Trust, Inc. (FBRT)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against Franklin BSP Realty Trust, Inc. (\u201cFBRT\u201d) (NYSE: FBRT) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding FBRT\u2019s prospects and ability to maintain the $0.355 dividend between <strong>November 5, 2024 and February 11, 2026<\/strong>. If you purchased FBRT shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N95eFUWfGz5xdCjlqBlHdnefBzPgzAuujIkmWWLfR9HWAkiygpOi3BfHar1bL7Njkah4VmeLVK7Ig4bhMkMR5_VYsq-vkM8NiKUURGPbW90=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n1-SFfejekyIjZgH4o9xZIWL7fVC6Tauan0tRSSGdt8wQ2pVSWLjNTyVHNzNmPKMgc_wZNWVuDk8dtt8KaSwMzzYsqbKuAgPRPZ43nCbZlnzct2_HzCylwhdZ_nGSO9SVa6D03PoVolfbq8sdvMcgJc9W72a3q5ZKuhItsyeBIfB5Gd92nXKrq0V7y72Lt0U\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/franklin-bsp-realty-trust\/<\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is April 27, 2026.<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Aquestive Therapeutics, Inc. (AQST)<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The shareholder class action lawsuit filed against Aquestive Therapeutics, Inc. (\u201cAquestive\u201d) (NASDAQ: AQST) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding Aquestive\u2019s New Drug Application for Anaphylm between <strong>June 16, 2025 and January 8, 2026<\/strong>. If you purchased Aquestive shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N95eFUWfGz5xdCjlqBlHdnefBzPgzAuujIkmWWLfR9H66NcQgpY3UY6tz_7CrARaxwTCZITjB0hm9E6wYD97-Ip-Aikr7tMq25BY8hV4O1g=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n1-SFfejekyIjZgH4o9xZIWL7fVC6Tauan0tRSSGdt_4FPlu9ybtqvA3EaOie3IW5BVfqOxZeZmBgRUgHRN5PT06d54BkvrkKnmnVZQ2qjWGXCAwjNrqsc5sJXPo_P5Y2wiSGBOIxDXz1S3dGY32WluA3wqVjXwDcXmaDcNUivE=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/aquestive-therapeutics\/<\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is\u00a0May 4, 2026.<\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CT8km9B1GEgmk4r8J2dFYiUzL0EPL5fUDGZAlXA7kM-NTf66foSz1gZxaxT6IVy2tmTVBAJkZmnhpdbYJMx5fWbx1vpiYDHNIPRnWUqzuog=\" rel=\"nofollow\" target=\"_blank\">https:\/\/holzerlaw.com\/<\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N95eFUWfGz5xdCjlqBlHdnefBzPgzAuujIkmWWLfR9FKxidxcp9FNkm8FiyFZyPmJwDATZcmEsyHN439WlGtqo0fS2HP2dkvpsQxkG5qll8=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzBhZGI0ZmMtNmNjNC00OTdlLWE4MzktMTE2M2ZiOTI3YWI1LTExOTIzMzYtMjAyNi0wMy0yNC1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, March 24, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: REGENXBIO Inc. (RGNX) The shareholder class action lawsuit filed against REGENXBIO Inc. (\u201cREGENXBIO\u201d) (NASDAQ: RGNX) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding the efficacy and safety of REGENXBIO\u2019s RGX-111 trial study between February 9, 2022 and January 27, 2026. If you purchased REGENXBIO shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-946523","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, March 24, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: REGENXBIO Inc. (RGNX) The shareholder class action lawsuit filed against REGENXBIO Inc. (\u201cREGENXBIO\u201d) (NASDAQ: RGNX) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding the efficacy and safety of REGENXBIO\u2019s RGX-111 trial study between February 9, 2022 and January 27, 2026. If you purchased REGENXBIO shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit &hellip; Continue reading &quot;Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-24T14:27:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC\",\"datePublished\":\"2026-03-24T14:27:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/\"},\"wordCount\":533,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/\",\"name\":\"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=\",\"datePublished\":\"2026-03-24T14:27:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/","og_locale":"en_US","og_type":"article","og_title":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","og_description":"ATLANTA, March 24, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: REGENXBIO Inc. (RGNX) The shareholder class action lawsuit filed against REGENXBIO Inc. (\u201cREGENXBIO\u201d) (NASDAQ: RGNX) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding the efficacy and safety of REGENXBIO\u2019s RGX-111 trial study between February 9, 2022 and January 27, 2026. If you purchased REGENXBIO shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit &hellip; Continue reading \"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-24T14:27:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC","datePublished":"2026-03-24T14:27:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/"},"wordCount":533,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/","name":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=","datePublished":"2026-03-24T14:27:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NzIxNiM3NDk5ODI5IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-regenxbio-inc-rgnx-franklin-bsp-realty-trust-inc-fbrt-and-aquestive-therapeutics-inc-aqst-announced-by-holzer-h-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against REGENXBIO Inc. (RGNX), Franklin BSP Realty Trust, Inc. (FBRT), and Aquestive Therapeutics, Inc. (AQST) Announced by Holzer &amp; Holzer, LLC"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/946523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=946523"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/946523\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=946523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=946523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=946523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}